| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2249.2007.03475.X |
| P698 | PubMed publication ID | 17711492 |
| P2093 | author name string | T Wang | |
| J Kramer | |||
| S Ghosh | |||
| S Jana | |||
| R Alemzadeh | |||
| J Waukau | |||
| M Koppen | |||
| P Jailwala | |||
| S Ehlenbach | |||
| S Glisic-Milosavljevic | |||
| P2860 | cites work | B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 |
| Impaired post-thymic development of regulatory CD4+25+ T cells contributes to diabetes pathogenesis in BB rats | Q28582024 | ||
| At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction | Q33268352 | ||
| Inhibition of human CD4(+)CD25(+high) regulatory T cell function | Q34529239 | ||
| Thymic selection revisited: how essential is it? | Q35076679 | ||
| Partial remission phase of diabetes in children younger than age 10 years | Q35262726 | ||
| Type 1 diabetes: recent developments | Q35714822 | ||
| Treatment of type 1 diabetes with anti-T-cell agents: from T-cell depletion to T-cell regulation | Q35841816 | ||
| Residual beta-cell function and spontaneous clinical remission in type 1 diabetes mellitus: the role of puberty | Q42461506 | ||
| Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents | Q42503576 | ||
| Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children | Q42517345 | ||
| Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients | Q42522359 | ||
| Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system | Q44333441 | ||
| Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study | Q46528457 | ||
| Comparison of apoptosis and mortality measurements in peripheral blood mononuclear cells (PBMCs) using multiple methods | Q46733558 | ||
| Redefining the clinical remission period in children with type 1 diabetes | Q47885436 | ||
| Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes | Q57158832 | ||
| Seventeen-colour flow cytometry: unravelling the immune system | Q62577376 | ||
| A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies | Q73081435 | ||
| Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes | Q79386759 | ||
| Diagnosis and classification of diabetes mellitus | Q82064791 | ||
| 'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors | Q83184938 | ||
| P433 | issue | 1 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 75-82 | |
| P577 | publication date | 2007-08-17 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes | |
| P478 | volume | 150 |
| Q33490627 | Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation |
| Q33786819 | Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice |
| Q37143220 | Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro |
| Q64235971 | Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account? |
| Q35179133 | Evaluation of T regulatory cell apoptosis in children with newly recognized type 1 diabetes mellitus |
| Q51762715 | Genetic association of HLA DQB1 with CD4+CD25+(high) T-cell apoptosis in type 1 diabetes. |
| Q37040516 | Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis |
| Q38182297 | Immune modulation in humans: implications for type 1 diabetes mellitus. |
| Q82746957 | Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes |
| Q40108816 | Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it? |
| Q92170641 | The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno-metabolic mechanisms |
| Q84454567 | The role of NF-kappaB and Smad3 in TGF-beta-mediated Foxp3 expression |
Search more.